Vaxcyte, Inc. (PCVX)

NasdaqGS • Currently up 1.91 (+3.68%) in today's trading session

1 member of Congress has disclosed 5 trades in Vaxcyte, Inc. (PCVX) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 13 May 2026. Aggregate disclosed activity totals roughly $40K in purchases (midpoint estimates from bracketed disclosure amounts).

Vaxcyte, Inc. is currently trading at $53.87, positioned at 69% of its 52-week range ($29.08 – $65.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$53.87
24h Change
+1.91 (+3.68%)
52 Week Range
$29.08—$65.00
View on NASDAQ

Vaxcyte, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for PCVX

Select to highlight on chart
5 transactions
Compliance: 100%
Gilbert Cisneros13 May 20268 Jun 2026PurchaseStock$1,001 - $15,000-0.30%
Gilbert Cisneros12 May 20268 Jun 2026PurchaseStock$1,001 - $15,000-0.22%
Gilbert Cisneros28 Apr 20256 May 2025PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros15 Apr 20256 May 2025PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros14 Apr 20256 May 2025PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$7.78B

Volume

1.97M

Beta

1.24

P/E Ratio

-7.83

Fundamentals

EPS

$-6.88

Div. Yield

—

Open

$51.88

Day Range

$51.88 — $54.83

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Grant E. Pickering
IPO Date
2020-06-12
Website
vaxcyte.com

Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candid...

Earnings

Next Report

Q2 2026

5 Aug

EPS Est.

$-2.06

Rev. Est.

$12.5M

Days Until

42

Recent Quarters

Q1 20266 May
EPS$-2.30
Miss 29.4%
Q4 202524 Feb
EPS$-1.80
Miss 17.7%
Q3 20254 Nov
EPS$-1.56
Miss 22.8%
Q2 20256 Aug
EPS$-1.22
Miss 8.9%
Q1 20257 May
EPS$-1.04
Miss 2.0%
Q4 202425 Feb
EPS$-1.02
Beat 12.1%
Q3 20245 Nov
EPS$-0.83
Beat 24.6%
Q2 20246 Aug
EPS$-1.10
Miss 12.8%
Q1 20248 May
EPS$-0.85
Beat 24.8%
Q4 202327 Feb
EPS$-1.82
Miss 102.2%
Q3 20236 Nov
EPS$-0.91
Miss 15.2%
Q2 20238 Aug
EPS$-0.70
Miss 4.5%
Q1 20238 May
EPS$-0.70
Beat 12.5%
Q4 202227 Feb
EPS$-0.73
Beat 13.1%
Q3 20227 Nov
EPS$-0.93
Miss 16.3%
Q2 20228 Aug
EPS$-0.80
Miss 15.9%
Q1 20229 May
EPS$-0.68
Miss 21.4%
Q4 202128 Feb
EPS$-0.54
Miss 17.4%
Q3 202110 Nov
EPS$-0.51
Miss 8.5%
Q2 202111 Aug
EPS$-0.46
Beat 0.0%
Q1 202111 May
EPS$-0.41
Beat 0.0%
Q4 202029 Mar
EPS$-0.41
Beat 14.6%
Q3 202012 Nov
EPS$-0.41
Beat 2.4%
Q2 202012 Aug
EPS$-1.72
Miss 35.4%
Q1 202015 Jun
EPS$-3.69
Q4 201931 Mar
EPS$-6.70
Q2 201930 Sept
EPS$-2.93
Q1 201930 Jun
EPS$-2.90
Q4 201831 Mar
EPS$-3.72

3 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

AAPL

Apple Inc.

20
$293.08-1.22 (-0.41%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

SPY

State Street SPDR S&P 500 ETF Trust

17
$733.24-0.34 (-0.05%)
Financial Services
Held by same politician
1 politician
View Stock

WBI

WaterBridge Infrastructure LLC

17
$28.31-0.28 (-0.98%)
Energy
Held by same politician
1 politician
View Stock

Frequently Asked Questions about PCVX

Which members of Congress have traded PCVX?
1 member of Congress has disclosed 5 trade in Vaxcyte, Inc. (PCVX) under the STOCK Act: Gilbert Cisneros.
When was PCVX most recently disclosed by Congress?
The most recent PCVX disclosure was a purchase by Gilbert Cisneros on 13 May 2026.
What is the total disclosed congressional trading volume for PCVX?
Members of Congress have disclosed approximately $40K in PCVX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in PCVX?
This PCVX page updates as soon as new STOCK Act disclosures are filed for Vaxcyte, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.